1037 — Maxnerva Technology Services Income Statement
0.000.00%
Last trade - 00:00- HK$342.49m
- HK$225.21m
- CNY707.58m
Annual income statement for Maxnerva Technology Services, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 596 | 832 | 678 | 559 | 708 |
| Cost of Revenue | |||||
| Gross Profit | 114 | 127 | 96.8 | 87.9 | 106 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 560 | 800 | 689 | 570 | 720 |
| Operating Profit | 36.1 | 32.4 | -11.1 | -11.2 | -12 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 37.6 | 30.5 | -14.2 | -9.06 | -11.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 34.3 | 27.8 | -16.8 | -12.4 | -14.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 34.3 | 27.8 | -16.8 | -12.4 | -14.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 34.3 | 27.8 | -16.8 | -12.4 | -14.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.049 | 0.04 | -0.012 | -0.016 | -0.022 |